ha 1004 has been researched along with African Lymphoma in 2 studies
N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faris, M | 1 |
| Gaskin, F | 1 |
| Parsons, JT | 1 |
| Fu, SM | 1 |
| Lazdins, J | 1 |
| Zompetta, C | 1 |
| Grimaldi, S | 1 |
| Barile, G | 1 |
| Venanzoni, M | 1 |
| Frati, L | 1 |
| Faggioni, A | 1 |
2 other studies available for ha 1004 and African Lymphoma
| Article | Year |
|---|---|
CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antibodies, Monoclonal; Antigens, CD; Antigens, Diffe | 1994 |
TPA induction of Epstein-Barr virus early antigens in Raji cells is blocked by selective protein kinase-C inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, Neoplasm; Antigens, Viral; Burkitt Lymphoma | 1987 |